Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hydroxychloroquine Sulphate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Recipient : University of Minnesota
Deal Size : Undisclosed
Deal Type : Collaboration
Rising Pharmaceuticals and Laurus Labs Partner to Support the University of Minnesota
Details : Rising Pharmaceuticals and its partner Laurus will supply hydroxychloroquine to support University of Minnesota's study on hydroxychloroquine as a treatment of COVID-19.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
March 27, 2020
Lead Product(s) : Hydroxychloroquine Sulphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Recipient : University of Minnesota
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?
Reset All
